 |
|
Preparticipation Cardiovascular Screening for US Collegiate Student-Athletes
Glen C. Pfister, BS;
James C. Puffer, MD;
Barry J. Maron, MD
JAMA. 2000;283:1597-1599.
Context Sudden death in young competitive athletes due to unsuspected cardiovascular disease has heightened interest in preparticipation screening.
Objective To assess screening practices for detecting potentially lethal cardiovascular diseases in college-aged student-athletes.
Design, Setting, and Participants A total of 1110 National Collegiate Athletic Association member colleges and universities were surveyed between 1995 and 1997, with 879 (79%) responding to the questionnaire.
Main Outcome Measures Information on the administration and scope of the preparticipation screening process was obtained from the team physician or athletic director; preparticipation screening forms were evaluated for content and compared with 12 items recommended by the 1996 American Heart Association (AHA) consensus panel screening guidelines.
Results Preparticipation screening was a requirement at 855 (97%) of 879 schools, was performed on campus at 713 schools (81%), and was required annually by 446 schools (51%). Team physicians were responsible for examinations at 603 (85%) of 713 schools with on-campus screening, although 135 of these schools (19%) also approved nurse practitioners and 244 schools (34%) allowed athletic trainers to perform examinations. Of the history and physical examination screening forms analyzed from 625 institutions, only 163 schools (26%) had forms that contained at least 9 of the recommended 12 AHA screening guidelines and were judged to be adequate, whereas 150 (24%) contained 4 or fewer of these parameters and were considered to be inadequate. Smaller Division III schools were more likely than larger Division I schools to have inadequate screening forms (30% vs 14%; P<.001). Relevant items that were omitted from more than 40% of the screening forms included history of exertional chest pain, dyspnea, or fatigue; familial heart disease or premature sudden death; and physical stigmata or family history of Marfan syndrome.
Conclusion The preparticipation screening process used by many US colleges and universities may have limited potential to detect (or raise the suspicion of) cardiovascular abnormalities capable of causing sudden death in competitive student-athletes.
Author Affiliations: Cardiovascular Research Division, Minneapolis Heart Institute Foundation, Minneapolis, Minn (Mr Pfister and Dr Maron), and Division of Sports Medicine, Department of Family Medicine, UCLA School of Medicine, Los Angeles, Calif (Dr Puffer).
RELATED ARTICLE
March 22/29, 2000
JAMA. 2000;283(12):1629-1630.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Electrocardiograms Should Be Included in Preparticipation Screening of Athletes
Myerburg and Vetter
Circulation 2007;116:2616-2626.
FULL TEXT
Recommendations and Considerations Related to Preparticipation Screening for Cardiovascular Abnormalities in Competitive Athletes: 2007 Update: A Scientific Statement From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation
Maron et al.
Circulation 2007;115:1643-1655.
FULL TEXT
Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening Program
Corrado et al.
JAMA 2006;296:1593-1601.
ABSTRACT
| FULL TEXT
Brief communication: Cardiovascular screening practices of major North American professional sports teams.
Harris et al.
ANN INTERN MED 2006;145:507-511.
ABSTRACT
| FULL TEXT
Medical and Legal Issues in the Cardiovascular Evaluation of Competitive Athletes
Paterick et al.
JAMA 2005;294:3011-3018.
ABSTRACT
| FULL TEXT
Task Force 1: Preparticipation screening and diagnosis of cardiovascular disease in athletes
Maron et al.
J Am Coll Cardiol 2005;45:1322-1326.
FULL TEXT
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology
Corrado et al.
Eur Heart J 2005;26:516-524.
ABSTRACT
| FULL TEXT
The preparticipation physical examination for athletics: a systematic review of current recommendations
Carek and Mainous
BMJ 2003;327:E170-173.
ABSTRACT
| FULL TEXT
Sudden Death in Young Athletes
Maron
NEJM 2003;349:1064-1075.
FULL TEXT
Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy
Maron et al.
J Am Coll Cardiol 2003;41:974-980.
ABSTRACT
| FULL TEXT
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Priori et al.
Eur Heart J 2001;22:1374-1450.
Role of DNA testing for diagnosis, management, and genetic screening in long QT syndrome, hypertrophic cardiomyopathy, and Marfan syndrome
VINCENT
Heart 2001;86:12-14.
FULL TEXT
Preparticipation Cardiovascular Screening for Young Athletes
Carek et al.
JAMA 2000;284:957-958.
FULL TEXT
Cardiovascular Screening for College Athletes
Journal Watch Cardiology 2000;2000:9-9.
FULL TEXT
|
